1,1,1-Trifluoro-4-isopropylaminopent-3-en-2-one, 250mg

(E)-2-(4-(4-(benzo[d]oxazol-2-yl)styryl)phenyl)-5-methylbenzo[d]oxazole, 98%, 500g

(5-fluoro-1-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid, 95.0%, 1g

D-luciferin sodium salt, min 99%, for biochemistry, 10 mg, glass packaging

Tert-butyl (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-2-yl)carbamate, 98%, 5g

2,2'-(2-Vinylanthracene-9,10-diylidene)bis(1,3-dithiole), 97% mix TBC as stabilizer, 100mg

2-CHLORO-5-FLUORO-4-IODO-3-METHYLPYRIDINE, 95%, 250mg

3-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

N-Methylpyrrolidin-3-amine, 95.0%, 1g

Ethanedithioamide, 97.0%, 10g

7-METHOXY-1,4-BENZOTHIAZIN-3-ONE, 97.0%, 5g

3-Methoxy-2-nitropyridine, 97.0%, 100g

2-(4-Ethoxy-3-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g